Mogelijk gemaakt door 
Translate
Translate
Dr. Martens plc
Notification of transaction by Person Closely Associated with a PDMR
Dr. Martens plc (the ‘Company’) announces that on 26 September 2024 the following transaction in the Company’s ordinary shares was undertaken by a person closely associated with a director / person discharging managerial responsibility (‘PDMR’).
The notification set out below is provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.
|
1. |
Details of PDMR / person closely associated with them |
|||||
|
a) |
Name |
Katie Wilson |
||||
|
2. |
Reasons for the notification |
|||||
|
a) |
Position / status |
Person Closely Associated with Giles Wilson, Chief Financial Officer and PDMR |
||||
|
b) |
Initial notification / amendment |
Initial notification |
||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Full name of the entity |
Dr. Martens plc |
||||
|
b) |
Legal Entity Identifier code |
213800QPT8YM6NQZPH28 |
||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument Identification Code |
Ordinary Shares of GBP 0.01 each
|
||||
|
b) |
Nature of the transaction |
Purchase of Ordinary Shares |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information Aggregated volume Price |
N/A – single transaction |
||||
|
e) |
Date of the transaction |
26 September 2024 |
||||
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
||||
